The defined biomimetic nanovaccine features multivalent IL-15 self-transpresentation, directional presentation of tumor antigen epitopes via major histocompatibility complex (MHC) molecule, and co-stimulatory molecules anchoring through a programmable procedure. The gene discussed is IL15; the disease is neoplasm.